United States-Israel Health Technologies Cooperation Act

3/18/2024, 9:24 PM
Referred to the Subcommittee on Health.
Bill 118 hr 4076, also known as the United States-Israel Health Technologies Cooperation Act, aims to promote collaboration between the United States and Israel in the field of health technologies. The bill recognizes Israel as a global leader in health technology innovation and seeks to leverage this expertise to benefit both countries.

Specifically, the bill calls for the establishment of a joint United States-Israel Health Technologies Cooperation Program. This program would facilitate partnerships between American and Israeli researchers, companies, and healthcare providers to develop and commercialize innovative health technologies. The goal is to improve healthcare outcomes, increase access to cutting-edge treatments, and drive economic growth in both countries.

Additionally, the bill directs the United States Agency for International Development (USAID) to prioritize funding for health technology projects that involve collaboration between the US and Israel. This will help ensure that resources are allocated to initiatives that have the potential to make a significant impact on global health. Overall, the United States-Israel Health Technologies Cooperation Act seeks to strengthen the relationship between the two countries and harness the power of innovation to address pressing healthcare challenges. By fostering collaboration and sharing expertise, the bill aims to drive progress in the field of health technologies and improve the lives of people around the world.
Congress
118

Number
HR - 4076

Introduced on
2023-06-13

# Amendments
0

Sponsors
+5

Cosponsors
+5

Variations and Revisions

6/13/2023

Status of Legislation

Bill Introduced
Introduced to House
House to Vote
Introduced to Senate
Senate to Vote

Purpose and Summary

Referred to the Subcommittee on Health.
Bill 118 hr 4076, also known as the United States-Israel Health Technologies Cooperation Act, aims to promote collaboration between the United States and Israel in the field of health technologies. The bill recognizes Israel as a global leader in health technology innovation and seeks to leverage this expertise to benefit both countries.

Specifically, the bill calls for the establishment of a joint United States-Israel Health Technologies Cooperation Program. This program would facilitate partnerships between American and Israeli researchers, companies, and healthcare providers to develop and commercialize innovative health technologies. The goal is to improve healthcare outcomes, increase access to cutting-edge treatments, and drive economic growth in both countries.

Additionally, the bill directs the United States Agency for International Development (USAID) to prioritize funding for health technology projects that involve collaboration between the US and Israel. This will help ensure that resources are allocated to initiatives that have the potential to make a significant impact on global health. Overall, the United States-Israel Health Technologies Cooperation Act seeks to strengthen the relationship between the two countries and harness the power of innovation to address pressing healthcare challenges. By fostering collaboration and sharing expertise, the bill aims to drive progress in the field of health technologies and improve the lives of people around the world.
Alternative Names
Official Title as IntroducedTo authorize funding for a bilateral cooperative program with Israel for the development of health technologies.

Policy Areas
Health

Potential Impact
Advanced technology and technological innovations•
Computers and information technology•
Drug safety, medical device, and laboratory regulation•
Health information and medical records•
Health programs administration and funding•
Health technology, devices, supplies•
Immunology and vaccination•
Infectious and parasitic diseases•
International organizations and cooperation•
Israel•
Medical tests and diagnostic methods•
Middle East

Comments

Recent Activity

Latest Action6/16/2023
Referred to the Subcommittee on Health.